Dissecting cellular heterogeneity and intercellular communication in cholangiocarcinoma: implications for individualized therapeutic strategies

• Published in: Frontiers in genetics Vol. 14; p. 1241834
• Main Authors: Zhou, Zun-Qiang, Zhang, Yi, Xu, Zi-Yang, Tang, Xiao-Li, Chen, Xiao-Hua, Guan, Jiao, Zhang, Zheng-Yun
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 04.01.2024
• Subjects: cholangiocarcinoma; fibroblas; Genetics; individualized therapy approach; single-cell RNA sequencing; T cell; single-cell RNA sequencing; individualized therapy approach; cholangiocarcinoma; fibroblas; T cell
• ISSN: 1664-8021; 1664-8021
• DOI: 10.3389/fgene.2023.1241834

Cholangiocarcinoma is characterized by significant cellular heterogeneity and complex intercellular communication, which contribute to its progression and therapeutic resistance. Therefore, unraveling this complexity is essential for the development of effective treatments. We employed single-cell RNA sequencing (scRNA-seq) to investigate cellular heterogeneity and intercellular communication in cholangiocarcinoma and adjacent normal tissues from two patients. Distinct cell types were identified, and gene ontology analyses were conducted to determine enriched pathways. Moreover, cell-cell communications were analyzed using CellChat, a computational framework. Additionally, we performed sub-clustering analysis of T cells and fibroblasts. The scRNA-seq analysis revealed distinct cell clusters and diverse cellular compositions of cholangiocarcinoma. CellChat analysis underscored an amplified outgoing signal from fibroblasts within the tumor, suggesting their pivotal role in the tumor microenvironment. Furthermore, T cell sub-clustering analysis revealed an active immune response within the tumor and new tumor-specific T cell clonotypes, suggesting scope for targeted immunotherapies. Moreover, fibroblast sub-clustering analysis indicated distinct functional states and highlighted the role of activated fibroblasts in shaping intercellular communication, particularly via CD99 and FN1 signaling. Our findings reveal the intricate cellular heterogeneity and dynamic intercellular communication in cholangiocarcinoma, providing valuable insights into disease progression and potential therapeutic strategies.